Loading candles…
Zota Health Care Limited operates in the pharmaceutical, ayurveda, nutraceutical, and healthcare industries. The company manufactures, markets, and exports a range of pharmaceutical, ayurvedic, nutraceutical, and over-the-counter products to semi-regulated and regulated markets across Asia, Africa, Russia, and Latin America. It also engages in the distribution of healthcare products both domestically and internationally. Among its initiatives is the DavaIndia program, which establishes franchised retail outlets in India aimed at improving access to generic medicines. The company's geographical reach includes India, Asia, Africa, the Commonwealth of Independent States (CIS) region, Russian countries, and Latin America. No information is provided about its incorporation year, founders, key management, subsidiaries, or stock exchange listings.
This page is a live market overview for ZOTA HEALTH CARE LIMITED (ZOTA) on the NSE. As a listed security, ZOTA HEALTH CARE LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for ZOTA before placing trades on tick2trade.
As of the latest feed, ZOTA last traded at ₹1,274.7 on NSE, up ₹28.3 (2.27%) from the previous close of ₹1,246.4. Today's session range is ₹1,242.2 – ₹1,286.4, against a 52-week band of ₹1,026.2 – ₹1,740. Traded volume today stands at 36.35K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for ZOTA in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether ZOTA is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for ZOTA HEALTH CARE LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in ZOTA. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated ZOTA option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters | 13 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters | 22 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 and other business matters | 4 Feb 2026 |
| Fund Raising | To consider Fund Raising and other business matters | 4 Sep 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters | 8 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025, dividend and other business matters | 29 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.